FLAVOMYCIN- bambermycins type a medicated article powder 
Huvepharma, Inc.

----------

FLAVOMYCIN® 4
(bambermycins Type A medicated article)

ANTIBIOTIC

To report suspected adverse drug events, for technical assistance or
to obtain a copy of the Safety Data Sheet (SDS), contact Huvepharma,
Inc. at 1-877-994-4883 or www.huvepharma.us. For additional information
about adverse drug experience reporting for animal drugs, contact FDA at
1-888-FDA-VETS or http://www.fda.gov/reportanimalae.

INDICATIONS FOR USE

For increased rate of weight gain and improved feed efficiency in broiler chickens,
growing-finishing swine and growing turkeys.

ACTIVE DRUG INGREDIENT

Bambermycins 4 grams per pound (8.8 grams per kilogram)

INGREDIENTS

Roughage products and/or calcium carbonate, dried bambermycins fermentation product,
ethoxyquin (a preservative), mineral oil.

MIXING DIRECTIONS AND INDICATIONS ON REVERSE SIDE

WITHDRAWAL PERIODS
No withdrawal period is required when used according to labeling.

FOR USE IN MANUFACTURED FEEDS ONLY

USER SAFETY WARNINGS
Not For Human Use
Keep out of reach of children.

Restricted Drug (California) – Use only as directed

Net Weight – 50 pounds (22.68 kg)

Distributed by:
HUVEPHARMA, INC.
Peachtree City, GA 30269

FLAVOMYCIN® 4
(bambermycins Type A Medicated Article)

ANTIBIOTIC 

INDICATIONS FOR USE

Species

Bambermycins g/ton in

Type C medicated feed

Indication(s)

Broiler

Chickens

1-2*

Increased rate of weight gain;

improved feed efficiency

Growing-

Finishing

Swine

2

Increased rate of weight gain;

improved feed efficiency

2-4*

Increased rate of weight gain

Growing Turkeys

2

Increased rate of weight gain;

improved feed efficiency

1-2*

Improved feed efficiency

*Only a single level of bambermycins (e.g., 4 grams/ton bambermycins) can be indicated on a feed tag. A different feed tag must be submitted for each level of bambermycins needed for your complete feeding program.

MIXING DIRECTIONS:

It is recommended that Flavomycin® 4 be diluted with a suitable grain carrier before addition to the final feed. A dilution of 1 part of Flavomycin® 4 and 9 parts grain carrier is the suggested working intermediate preblend. The table below shows Flavomycin® 4 and working intermediate preblend addition levels for various commonly used feeds:

Feed

Bambermycins in Type C Medicated Feed (g/ton)

Pounds Flavomycin® 4 per Ton Type C      Medicated Feed 

     Pounds 1-9                 Intermediate

     Preblend per Ton       Type C Medicated       Feed

Broiler

Chickens

1

2

.25

.50

2.50

5.00

Growing-

Finishing

Swine

2

3

4

.50

.75

1.00

5.00

7.50

10.00

Growing

Turkeys

1

2

.25

.50

2.50

5.00

Thoroughly mix both working intermediate preblend and finished Type C medicated feed to ensure complete and uniform distribution of the Flavomycin® 4.

FEEDING DIRECTIONS:

Type C medicated feed containing Flavomycin® 4 should be fed continuously as the sole ration.

Huvepharma®

Approved by FDA under NADA #044-759

Bag Label Image

FLAVOMYCIN 
bambermycins type a medicated article powder
Product Information
Product TypeOTC TYPE A MEDICATED ARTICLE ANIMAL DRUGItem Code (Source)NDC:23243-2060
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BAMBERMYCINS (UNII: PP922A42V2) (BAMBERMYCINS - UNII:PP922A42V2) BAMBERMYCINS8.8 g  in 1 kg
Inactive Ingredients
Ingredient NameStrength
MINERAL OIL (UNII: T5L8T28FGP)  
CALCIUM CARBONATE (UNII: H0G9379FGK)  
Product Characteristics
Colorbrown ((Off White to Tan)) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:23243-2060-522.68 kg in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA04475912/04/2012
Labeler - Huvepharma, Inc. (619153559)
Registrant - Huvepharma EOOD (552691651)
Establishment
NameAddressID/FEIBusiness Operations
Huvepharma, Inc.883128204manufacture, analysis, label, pack, medicated animal feed manufacture

Revised: 5/2024
Document Id: bfe73b35-56db-4ea8-8e4d-ca4d8615b4ee
Set id: 226e3192-984d-4ff0-9e65-c1e54a78e522
Version: 8
Effective Time: 20240501
 
Huvepharma, Inc.